跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,009 条关于
“GEM 21S”
全部
7,009
临床试验
5,270
药物
1,300
机构
66
资讯
373
上个月
Lynch Regenerative Medicine Completes Enrollment in Phase II Trial of rhPDGF-BB for Full-Thickness Head and Neck Wound Healing
2个月前
GEM Commits Up to NT$500 Million to Senhwa Biosciences to Advance Oncology Pipeline
去年
Hinge Bio Secures $30 Million to Advance GEM-DIMER Platform for Autoimmune Therapies
去年
Technology-Assisted Health Coaching Fails to Achieve Significant Weight Loss in Primary Care Trial
上个月
Novel miRNA-129–Based Therapy Achieves Over 95% Tumor Shrinkage in Preclinical NSCLC Model, Halting Drug Resistance
11个月前
Hinge Bio Partners with Kyorin for $105M HB2198 Autoimmune Deal in Japan
8个月前
Revelation Biosciences Secures FDA Agreement for Streamlined Gemini Approval Pathway in Acute Kidney Injury
去年
Hinge Bio Strengthens Leadership Team and Publishes Promising Data for Novel Lupus Treatment HB2198
去年
Black Swan Graphene Partners with Ferro South Africa to Expand Graphene Technology Distribution
去年
EMA Postpones Decision on Krystal Biotech's B-VEC for Dystrophic Epidermolysis Bullosa
第 1 页,共 38 页
上一页
下一页